Daniel Wainstein

Part of Healthtech Solutions, Inc., Varian Biopharmaceuticals, Inc. is a private precision oncology company based in Naples, FL. Varian Bio is developing novel therapeutics for the treatment of cancer using precision oncology, which involves DNA testing to identify genetic mutations in tumors for more targeted treatment recommendations. Varian Bio's lead drug candidate, Var-101, is being developed in a topical formulation for the treatment of basal cell carcinoma, while Var-102, an oral formulation, is being developed for the treatment of various solid tumors, including non-small cell lung cancer, pancreatic cancer, and colorectal cancer. Varian Bio is also seeking additional precision oncology therapeutic candidates for its pipeline and exploring development collaborations. The CEO of the company is Jeffrey Blaine Davis. Varian Biopharmaceuticals was acquired by Healthtech Solutions, Inc. on May 07, 2021.

JMD Properties, Inc. is a content conversion service provider, developer, and integrator for the 3D Stereo and auto-stereo media industry. Its services include proprietary 3D reality splitter 2D to 3D conversion; stereo and multi-view consulting and integration; value added reseller of turnkey multi-view systems for digital signage. The company was founded in 1989 and is headquartered in Cheyenne, WY.